MedTrace Logo

Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy

NCT04039529 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-02-09

No results posted yet for this study

Summary

This study investigates whether a new image fusion technology can reduce patient radiation dose from CTs and/or procedure time during biopsies of lung, liver or kidney.

Conditions

  • Liver Biopsy
  • Lung Biopsy
  • Kidney Biopsy

Interventions

DEVICE

SCENERGY-guided Biopsy

Use of SCENERGY during a lung, liver or kidney biopsy

Sponsors & Collaborators

  • Temple University

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • Clear Guide Medical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-31
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04039529 on ClinicalTrials.gov